Skip to main content
OpenTrials
Completed

NCT Number: NCT05671237

The Effect of Bilateral Infraorbital+ Infratrochlear Nerve Block for Rhinoplasty Operations

The aim of our study is to examine the effect of bilateral infraorbital and infratrochlear nerve blocks for rhinoplasty operations on perioperative remifentanil need and postoperative pain scores.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Istanbul University, Department of Anesthesiology

Istanbul, 34093, Turkey (Türkiye)

About this study

Rhinoplasty operations are one of the most applied cosmetic surgeries in the world.

Depending on the procedure type and hemodynamic lability, the quality of the surgical field, perioperative and postoperative complications as well as the success of surgery are affected.To provide improved surgical field quality, controlled hypotension and high concentrations of inhalation anesthetics, magnesium sulfate, remifentanil, clonidine, calcium channel blockers, tranexamic acid, intravenous nitroglycerin have been used.

The American Society of Anesthesiology recommends using regional anesthesia methods and administering multimodal analgesia in every possible surgery. In our study we have performed bilaterral infraorbital an infratrochlear nerve blocks which are main nerves of the nose, for the patients of rhinoplasty. With blocking the infratrochlear and infraorbital nerves we will examine the need for remifentanil during surgery, postoperative pain scores.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients undergoing rhinoplasty surgery

Exclusion criteria

  • Bleeding disorder
  • Patient refusal
  • Age under 18

Treatment and study plan

bilateral infraorbital+infratrochlear block

Other

we will perform bilateral infraorbital+infratrochlear nerve block

Primary outcomes

  1. Remifentanil consumption

    Time frame: 6 hours

    We will compare the remifentanil consumption for the block performed and non-block group

Secondary outcomes

  1. Surgical bleeding grading

    Time frame: 6 hours

    We will compare the surgical bleeding scores for the block performed and non-block group

  2. Richmond agitation sedation scale

    Time frame: 6 hours

    We will compare the Richmond agitation sedation scale for the block performed and non-block group. +4 Combative +3 Very agitated +2 Agitated +1 Restless 0 Alert and calm -1 Drowsy -2 Light sedation -3 Moderate sedation -4 Deep sedation -5 Unarousable

  3. Numeric rating Scale

    Time frame: 6 hours

    We will compare the numeric rating scale for pain for the block performed and non-block group. The numeric rating scale (NRS) is a pain screening tool, commonly used to assess pain severity at that moment in time using a 0-10 scale, with zero meaning "no pain" and 10 meaning "the worst pain imaginable"

  4. Post-operative nausea and vomiting

    Time frame: 6 hours

    We will compare the Post-operative nausea and vomiting for the block performed and non-block group

  5. Need for analgesic after surgery

    Time frame: 6 hours

    We will compare the Need for analgesic after surgery for the block performed and non-block group

Sponsors and collaborators

Lead sponsor

Istanbul University

Other

Registry information

Official study title

The Effect of Bilateral Infraorbital+ Infratrochlear Nerve Block on Perioperative Remifentanil Consumption and Postoperative Pain Scores for Rhinoplasty Operations

Important dates

Study start
2022
Primary completion
2023
Study completion
2023
First posted
Jan 4, 2023
Registry last updated
Jun 5, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.